|
1
|
Enzinger PC and Mayer RJ: Esophageal
cancer. N Engl J Med. 349:2241–2252. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
McCann J: Esophageal cancers: changing
character, increasing incidence. J Natl Cancer Inst. 91:497–498.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Koshy M, Esiashvilli N, Landry JC, Thomas
CR Jr and Matthews RH: Multiple management modalities in esophageal
cancer: combined modality management approaches. Oncologist.
9:147–159. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Bartel DP: MicroRNAs: genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Lin J, Huang S, Wu S, et al: MicroRNA-423
promotes cell growth and regulates G(1)/S transition by targeting
p21Cip1/Waf1 in hepatocellular carcinoma. Carcinogenesis.
32:1641–1647. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Jovanovic M and Hengartner MO: miRNAs and
apoptosis: RNAs to die for. Oncogene. 25:6176–6187. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Stevanato L and Sinden JD: The effects of
microRNAs on human neural stem cell differentiation in two- and
three-dimensional cultures. Stem Cell Res Ther. 5:492009.
View Article : Google Scholar
|
|
9
|
Djuranovic S, Nahvi A and Green R: A
parsimonious model for gene regulation by miRNAs. Science.
331:550–553. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kasinski AL and Slack FJ: Epigenetics and
genetics. MicroRNAs en route to the clinic: progress in validating
and targeting microRNAs for cancer therapy. Nat Rev Cancer.
11:849–864. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
11
|
Valastyan S, Reinhardt F, Benaich N, et
al: A pleiotropically acting microRNA, miR-31, inhibits breast
cancer metastasis. Cell. 137:1032–1046. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Iorio MV, Visone R, Di Leva G, et al:
MicroRNA signatures in human ovarian cancer. Cancer Res.
67:8699–8707. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Iorio MV and Croce CM: MicroRNAs in
cancer: small molecules with a huge impact. J Clin Oncol.
27:5848–5856. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Calin GA and Croce CM: MicroRNA signatures
in human cancers. Nat Rev Cancer. 6:857–866. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Cho WC: OncomiRs: the discovery and
progress of microRNAs in cancers. Mol Cancer. 6:602007. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Xue Q, Sun K, Deng HJ, Lei ST, Dong JQ and
Li GX: MicroRNA-338-3p inhibits colorectal carcinoma cell invasion
and migration by targeting smoothened. Jpn J Clin Oncol. 44:13–21.
2014. View Article : Google Scholar
|
|
17
|
Sun K, Guo C, Deng HJ, Dong JQ, Lei ST and
Li GX: Construction of lentivirus-based inhibitor of
hsamicroRNA-338-3p with specific secondary structure. Acta
Pharmacol Sin. 34:167–175. 2013. View Article : Google Scholar
|
|
18
|
Tsuchiya S, Oku M, Imanaka Y, et al:
MicroRNA-338-3p and microRNA-451 contribute to the formation of
basolateral polarity in epithelial cells. Nucleic Acids Res.
37:3821–3827. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Yang M, Liu R, Sheng J, et al:
Differential expression profiles of microRNAs as potential
biomarkers for the early diagnosis of esophageal squamous cell
carcinoma. Oncol Rep. 29:169–176. 2013.
|
|
20
|
Chen X, Pan M, Han L, Lu H, Hao X and Dong
Q: miR-338-3p suppresses neuroblastoma proliferation, invasion and
migration through targeting PREX2a. FEBS Lett. 587:3729–3737. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Sun K, Deng HJ, Lei ST, Dong JQ and Li GX:
miRNA-338-3p suppresses cell growth of human colorectal carcinoma
by targeting smoothened. World J Gastroenterol. 19:2197–2207. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Bartel DP: MicroRNAs: target recognition
and regulatory functions. Cell. 136:215–233. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kloosterman WP and Plasterk RH: The
diverse functions of microRNAs in animal development and disease.
Dev Cell. 11:441–450. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Akanuma N, Hoshino I, Akutsu Y, et al:
MicroRNA-133a regulates the mRNAs of two invadopodia-related
proteins, FSCN1 and MMP14, in esophageal cancer. Br J Cancer.
110:189–198. 2014. View Article : Google Scholar :
|
|
25
|
Lee KH, Goan YG, Hsiao M, et al:
MicroRNA-373 (miR-373) post-transcriptionally regulates large tumor
suppressor, homolog 2 (LATS2) and stimulates proliferation in human
esophageal cancer. Exp Cell Res. 315:2529–2538. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ma WJ, Lv GD, Tuersun A, et al: Role of
microRNA-21 and effect on PTEN in Kazakh's esophageal squamous cell
carcinoma. Mol Biol Rep. 38:3253–3260. 2011. View Article : Google Scholar
|
|
27
|
Zhang M, Zhou S, Zhang L, et al: miR-518b
is downregulated, and involved in cell proliferation and invasion
by targeting Rap1b in esophageal squamous cell carcinoma. FEBS
Lett. 586:3508–3521. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Wang Z, Qiao Q, Chen M, et al: miR-625
downregulation promotes proliferation and invasion in esophageal
cancer by targeting Sox2. FEBS Lett. 588:915–921. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wang Y, Zang W, Du Y, et al: Mir-655
upregulation suppresses cell invasion by targeting pituitary
tumor-transforming gene-1 in esophageal squamous cell carcinoma. J
Transl Med. 11:3012013. View Article : Google Scholar
|
|
30
|
Kos A, Olde Loohuis NF, Wieczorek ML, et
al: A potential regulatory role for intronic microRNA-338-3p for
its host gene encoding apoptosis-associated tyrosine kinase. PLoS
One. 7:e310222012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Huang XH, Wang Q, Chen JS, et al:
Bead-based microarray analysis of microRNA expression in
hepatocellular carcinoma: miR-338 is downregulated. Hepatol Res.
39:786–794. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Peng Y, Liu YM, Li LC, Wang LL and Wu XL:
MicroRNA-338 inhibits growth, invasion and metastasis of gastric
cancer by targeting NRP1 expression. PLoS One. 9:e944222014.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Rowe RG and Weiss SJ: Navigating ECM
barriers at the invasive front: the cancer cell-stroma interface.
Annu Rev Cell Dev Biol. 25:567–595. 2009. View Article : Google Scholar
|
|
34
|
Buchheit CL, Weigel KJ and Schafer ZT:
Cancer cell survival during detachment from the ECM: multiple
barriers to tumour progression. Nat Rev Cancer. 14:632–641. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
MacDougall JR and Matrisian LM:
Contributions of tumor and stromal matrix metalloproteinases to
tumor progression, invasion and metastasis. Cancer Metastasis Rev.
14:351–362. 1995. View Article : Google Scholar : PubMed/NCBI
|
